Especially in hepatocellular carcinoma (HCC), accumulating studies have been reported that lncRNA HULC has a potential as a promising therapeutic target in HCC and it can accelerate liver cancer by inhibiting PTEN via autophagy cooperation to miR15a [25–27]. This evidence concerns the gene HULC and hepatocellular carcinoma.